Literature DB >> 15077158

Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.

Rolf Drivdahl1, Kathy H Haugk, Cynthia C Sprenger, Peter S Nelson, Marie K Tennant, Stephen R Plymate.   

Abstract

Overexpression of mac25 in the prostate cancer cell line M12 effects a dramatic reversal of the transformed phenotype. cDNA array analysis of RNA from cells overproducing the mac25 protein (M12/mac25) indicated upregulation of the sex determining transcription factor SOX9. In this study, we have confirmed increased expression of SOX9 in M12/mac25 cells and have further investigated the physiological effects of increased SOX9 production. Greatly increased levels of SOX9 RNA and mature protein were demonstrated in cells transfected with a SOX9 cDNA (M12/SOX9), and gel mobility shift assays confirmed binding of nuclear protein from these cells to an oligonucleotide containing the SOX9 consensus binding sequence. M12/SOX9 cells assumed the spindle-shaped morphology characteristic of M12/mac25 cells, suggesting that SOX9 mediates some effects of mac25. Elevated expression of SOX9 resulted in a decreased rate of cellular proliferation, cell cycle arrest in G0/G1, and increased sensitivity to apoptosis. Tumor development in athymic nude mice was inhibited by 80%. Finally, prostate-specific antigen and the androgen receptor, two genes whose expression is characteristic of differentiated cells, were both upregulated in M12/SOX9 cells. These data indicate that SOX9 contributes to growth regulation by mac25 via inhibition of cell growth and promotion of differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077158     DOI: 10.1038/sj.onc.1207603

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.

Authors:  Sangjun Lee; Dan Medina; Anna Tsimelzon; Syed K Mohsin; Sufeng Mao; Yun Wu; D Craig Allred
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

2.  SOXs in human prostate cancer: implication as progression and prognosis factors.

Authors:  Wei-de Zhong; Guo-qiang Qin; Qi-shan Dai; Zhao-dong Han; Shan-ming Chen; Xiao-hui Ling; Xin Fu; Chao Cai; Jia-hong Chen; Xi-bin Chen; Zhuo-yuan Lin; Ye-han Deng; Shu-lin Wu; Hui-chan He; Chin-lee Wu
Journal:  BMC Cancer       Date:  2012-06-15       Impact factor: 4.430

3.  Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis.

Authors:  Paul G Murray; Yichao Fan; Gillian Davies; Jianming Ying; Hua Geng; Ka Man Ng; Hongyu Li; Zifen Gao; Wenbin Wei; Shikha Bose; Jennifer Anderton; Georgia Kapatai; Gary Reynolds; Akihiko Ito; Teresa Marafioti; Ciaran Bj Woodman; Richard Ambinder; Qian Tao
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

4.  KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells.

Authors:  Hassan Sellak; Songwei Wu; Thomas M Lincoln
Journal:  Biochim Biophys Acta       Date:  2012-07-02

5.  Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.

Authors:  Cynthia C T Sprenger; Rolf H Drivdahl; Lillie B Woodke; Daniel Eyman; May J Reed; William G Carter; Stephen R Plymate
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

6.  Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.

Authors:  Thierry Passeron; Julio C Valencia; Takeshi Namiki; Wilfred D Vieira; Hélène Passeron; Yoshinori Miyamura; Vincent J Hearing
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

Review 7.  Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.

Authors:  A Fucic; A Aghajanyan; Z Culig; N Le Novere
Journal:  Pathol Oncol Res       Date:  2018-09-16       Impact factor: 3.201

8.  SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.

Authors:  Martin K Thomsen; Laurence Ambroisine; Sarah Wynn; Kathryn S E Cheah; Christopher S Foster; Gabrielle Fisher; Daniel M Berney; Henrik Møller; Victor E Reuter; Peter Scardino; Jack Cuzick; Narasimhan Ragavan; Paras B Singh; Francis L Martin; Christopher M Butler; Colin S Cooper; Amanda Swain
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

9.  Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.

Authors:  Nikola A Bowden; Amanda Croft; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

10.  SOX9 modulates cancer biomarker and cilia genes in pancreatic cancer.

Authors:  Hannah E Edelman; Sarah A McClymont; Tori R Tucker; Santiago Pineda; Rebecca L Beer; Andrew S McCallion; Michael J Parsons
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.